Nonalcoholic fatty liver disease (NAFLD) is a very common chronic hepatic disease, with nonalcoholic steatohepatitis (NASH) as a major and severe subcategory that can lead to cirrhosis and hepatocellular carcinoma, and thereby to a high mortality rate. Currently, there has been no approved drug to treat NAFLD or NASH. The current study has presented RLA8, a novel and balanced quadruple agonist for hepatic lipid metabolism and inflammation-related peroxisome proliferator-activated receptors (PPARs)-// and G protein-coupled receptor 40 (GPR40), as a NASH drug candidate.
View Article and Find Full Text PDFBackground: Immunotherapy is emerging as a promising cure for cancer. However, a severe problem in this area is the immune tolerance to tumor cells and tumor-associated antigens, as evidenced by the ability of cancer to escape immune surveillance. To overcome this problem this work examined the potential of improving the antigenicity of myeloma by metabolic engineering of its cell surface carbohydrate antigens (i.
View Article and Find Full Text PDFSpace Med Med Eng (Beijing)
October 2003
Objective: To find a method for evaluating the relationship between mechanical data and gait efficiently.
Method: Gait mechanical data of 27 young men (20-22 years) without history of the kinetic diseases were collected using a force-measuring system. The data were transformed into characteristic two-peak curves in vertical direction (z-axis).
Space Med Med Eng (Beijing)
April 2002
Objective: To provide a gait analysis system.
Method: The system is composed of general video devices and personal computer hardware. The techniques of digital video and digital image processing such as template matching, sub-pixel and motion estimate etc were employed to identify and trace the markers.
Tricolorin A (1), a structurally amazing resin glycoside with promising bioactivities from Ipomoea tricolor cav. (convolvulaceae), was synthesized in a total of 45 steps, with the longest linear sequence of 20 steps and overall yield of 0.65% from D-mannitol.
View Article and Find Full Text PDF